These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 2044441)

  • 1. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1990 Dec; 8(7):S187-91. PubMed ID: 2095388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
    Parving HH; Rossing P
    Curr Opin Nephrol Hypertens; 1994 May; 3(3):292-300. PubMed ID: 7922255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.
    Parving HH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S19-24. PubMed ID: 1382160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
    Larsen M; Hommel E; Parving HH; Lund-Andersen H
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):505-9. PubMed ID: 2265765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G; Repetto M; Calvi C; Ciabattoni M; Rossi C; Robaudo C
    Nephrol Dial Transplant; 1998; 13 Suppl 8():11-5. PubMed ID: 9870419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving strategies for renoprotection: diabetic nephropathy.
    Parving HH; Hovind P; Rossing K; Andersen S
    Curr Opin Nephrol Hypertens; 2001 Jul; 10(4):515-22. PubMed ID: 11458033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High blood pressure is a major factor in progression of diabetic nephropathy.
    Parving HH; Hommel E
    J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW; Estacio RO; Esler A; Mehler P
    Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in insulin-dependent diabetes.
    Norgaard K
    Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.